請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5295完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳彥榮(Yen-Rong Chen) | |
| dc.contributor.author | Woan-Ing Twu | en |
| dc.contributor.author | 涂琬瑛 | zh_TW |
| dc.date.accessioned | 2021-05-15T17:55:17Z | - |
| dc.date.available | 2019-07-29 | |
| dc.date.available | 2021-05-15T17:55:17Z | - |
| dc.date.copyright | 2014-07-29 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-07-15 | |
| dc.identifier.citation | Apte, U., Thompson, M.D., Cui, S., Liu, B., Cieply, B., and Monga, S.P. (2008). Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 47, 288-295.
Bao, B., Ahmad, A., Kong, D., Ali, S., Azmi, A.S., Li, Y., Banerjee, S., Padhye, S., and Sarkar, F.H. (2012). Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. PLoS One 7, e43726. Bengochea, A., de Souza, M.M., Lefrancois, L., Le Roux, E., Galy, O., Chemin, I., Kim, M., Wands, J.R., Trepo, C., Hainaut, P., et al. (2008). Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 99, 143-150. Bogaerts, E., Heindryckx, F., Vandewynckel, Y.P., Van Grunsven, L.A., and Van Vlierberghe, H. (2014). The roles of transforming growth factor-beta, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review). Int J Oncol 44, 1015-1022. Boulter, L., Govaere, O., Bird, T.G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R.A., Seo, S.S., Spee, B., Van Rooijen, N., et al. (2012). Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 18, 572-579. Cannito, S., Paternostro, C., Busletta, C., Bocca, C., Colombatto, S., Miglietta, A., Novo, E., and Parola, M. (2014). Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases. Histol Histopathol 29, 33-44. Carpino, G., Renzi, A., Onori, P., and Gaudio, E. (2013). Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. Int J Mol Sci 14, 20112-20130. Chen, S., Xu, L., Lin, N., Pan, W., Hu, K., and Xu, R. (2011). Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells. Life Sci 89, 975-981. Chen, Y., Wong, P.P., Sjeklocha, L., Steer, C.J., and Sahin, M.B. (2012a). Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture. Hepatology 55, 563-574. Chen, Y.F., Tseng, C.Y., Wang, H.W., Kuo, H.C., Yang, V.W., and Lee, O.K. (2012b). Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 55, 1193-1203. Clevers, H., and Nusse, R. (2012). Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205. Cunningham, L.A., Candelario, K., and Li, L. (2012). Roles for HIF-1alpha in neural stem cell function and the regenerative response to stroke. Behav Brain Res 227, 410-417. Dong, Z.Z., Yao, M., Wang, L., Wu, W., Gu, X., and Yao, D.F. (2013). Hypoxia-inducible factor-1alpha: molecular-targeted therapy for hepatocellular carcinoma. Mini Rev Med Chem 13, 1295-1304. Espanol-Suner, R., Carpentier, R., Van Hul, N., Legry, V., Achouri, Y., Cordi, S., Jacquemin, P., Lemaigre, F., and Leclercq, I.A. (2012). Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143, 1564-1575 e1567. Friedman, S.L. (2008). Hepatic fibrosis -- overview. Toxicology 254, 120-129. Ge, W.S., Wang, Y.J., Wu, J.X., Fan, J.G., Chen, Y.W., and Zhu, L. (2014). beta-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/beta-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep 9, 2145-2151. Hemmann, S., Graf, J., Roderfeld, M., and Roeb, E. (2007). Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46, 955-975. Herlyn, D., Herlyn, M., Steplewski, Z., and Koprowski, H. (1979). Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 9, 657-659. Holland, J.D., Klaus, A., Garratt, A.N., and Birchmeier, W. (2013). Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 25, 254-264. Imanirad, P., and Dzierzak, E. (2013). Hypoxia and HIFs in regulating the development of the hematopoietic system. Blood Cells Mol Dis 51, 256-263. Kanta, J., and Chlumska, A. (1991). Regenerative ability of hepatocytes is inhibited in early stages of liver fibrosis. Physiol Res / Academia Scientiarum Bohemoslovaca 40, 453-458. Katoh, M. (2011). Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr Pharm Biotechnol 12, 160-170. Kuhl, S.J., and Kuhl, M. (2013). On the role of Wnt/beta-catenin signaling in stem cells. Biochim Biophys Acta 1830, 2297-2306. Kumar, V., Abbas, A.K., Aster, J.C., and Robbins, S.L. (2013). Robbins basic pathology (Philadelphia, PA: Elsevier/Saunders). Kuramitsu, K., Sverdlov, D.Y., Liu, S.B., Csizmadia, E., Burkly, L., Schuppan, D., Hanto, D.W., Otterbein, L.E., and Popov, Y. (2013). Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol 183, 182-194. Lee, U.E., and Friedman, S.L. (2011). Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25, 195-206. Lefton, H.B., Rosa, A., and Cohen, M. (2009). Diagnosis and epidemiology of cirrhosis. Medical Clin North Am 93, 787-799, vii. Maetzel, D., Denzel, S., Mack, B., Canis, M., Went, P., Benk, M., Kieu, C., Papior, P., Baeuerle, P.A., Munz, M., et al. (2009). Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 11, 162-171. Malato, Y., Naqvi, S., Schurmann, N., Ng, R., Wang, B., Zape, J., Kay, M.A., Grimm, D., and Willenbring, H. (2011). Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 121, 4850-4860. Marshall, A., Rushbrook, S., Davies, S.E., Morris, L.S., Scott, I.S., Vowler, S.L., Coleman, N., and Alexander, G. (2005). Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 128, 33-42. Mathieu, J., Zhang, Z., Zhou, W., Wang, A.J., Heddleston, J.M., Pinna, C.M., Hubaud, A., Stadler, B., Choi, M., Bar, M., et al. (2011). HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71, 4640-4652. Mazumdar, J., O'Brien, W.T., Johnson, R.S., LaManna, J.C., Chavez, J.C., Klein, P.S., and Simon, M.C. (2010). O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12, 1007-1013. Michalopoulos, G.K. (2007). Liver regeneration. J Cell Physiol 213, 286-300. Moeini, A., Cornella, H., and Villanueva, A. (2012). Emerging Signaling Pathways in Hepatocellular Carcinoma. Liver cancer 1, 83-93. Mohyeldin, A., Garzon-Muvdi, T., and Quinones-Hinojosa, A. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7, 150-161. Munz, M., Baeuerle, P.A., and Gires, O. (2009). The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69, 5627-5629. Ogawa, K., Tanaka, S., Matsumura, S., Murakata, A., Ban, D., Ochiai, T., Irie, T., Kudo, A., Nakamura, N., Tanabe, M., et al. (2014). EpCAM-targeted therapy for human hepatocellular carcinoma. Ann Surg Oncol 21, 1314-1322. Osta, W.A., Chen, Y., Mikhitarian, K., Mitas, M., Salem, M., Hannun, Y.A., Cole, D.J., and Gillanders, W.E. (2004). EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64, 5818-5824. Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R., and Sarin, S.K. (2013). From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence. Liver cancer 2, 367-383. Schepers, A., and Clevers, H. (2012). Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb Perspect Biol 4, a007989. Semenza, G.L. (2007). Hypoxia-Inducible Factor 1 (HIF-1) Pathway. Sci STKE 2007, 407-cm8. Shin, S., and Kaestner, K.H. (2014). The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells. Curr Top Dev Biol 107, 269-292. Si-Tayeb, K., Noto, F.K., Nagaoka, M., Li, J., Battle, M.A., Duris, C., North, P.E., Dalton, S., and Duncan, S.A. (2010). Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51, 297-305. Taura, K., Miura, K., Iwaisako, K., Osterreicher, C.H., Kodama, Y., Penz-Osterreicher, M., and Brenner, D.A. (2010). Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027-1036. Trzpis, M., McLaughlin, P.M., van Goor, H., Brinker, M.G., van Dam, G.M., de Leij, L.M., Popa, E.R., and Harmsen, M.C. (2008). Expression of EpCAM is up-regulated during regeneration of renal epithelia. J Pathol 216, 201-208. Wang, Y., Huang, Y., Guan, F., Xiao, Y., Deng, J., Chen, H., Chen, X., Li, J., Huang, H., and Shi, C. (2013). Hypoxia-inducible factor-1alpha and MAPK co-regulate activation of hepatic stellate cells upon hypoxia stimulation. PLoS One 8, e74051. Wells, R.G. (2008). Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 12, 759-768, viii. Williams, M.J., Clouston, A.D., and Forbes, S.J. (2014). Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 146, 349-356. Yamada, S., Utsunomiya, T., Morine, Y., Imura, S., Ikemoto, T., Arakawa, Y., Kanamoto, M., Iwahashi, S., Saito, Y., Takasu, C., et al. (2014). Expressions of Hypoxia-Inducible Factor-1 and Epithelial Cell Adhesion Molecule are Linked with Aggressive Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy. Ann Surg Oncol. 21, 436-442 Yamashita, T., Budhu, A., Forgues, M., and Wang, X.W. (2007). Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res 67, 10831-10839. Yamashita, T., Forgues, M., Wang, W., Kim, J.W., Ye, Q., Jia, H., Budhu, A., Zanetti, K.A., Chen, Y., Qin, L.X., et al. (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68, 1451-1461. Yanger, K., and Stanger, B.Z. (2011). Facultative stem cells in liver and pancreas: fact and fancy. Dev Dyn 240, 521-529. Yoon, S.M., Gerasimidou, D., Kuwahara, R., Hytiroglou, P., Yoo, J.E., Park, Y.N., and Theise, N.D. (2011). Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology 53, 964-973. Zhang, L., Theise, N., Chua, M., and Reid, L.M. (2008). The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 48, 1598-1607. Zhang, Q., Bai, X., Chen, W., Ma, T., Hu, Q., Liang, C., Xie, S., Chen, C., Hu, L., Xu, S., et al. (2013). Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis 34, 962-973. Zhao, J.H., Luo, Y., Jiang, Y.G., He, D.L., and Wu, C.T. (2011). Knockdown of beta-Catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1alpha. Cancer Invest 29, 377-382. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5295 | - |
| dc.description.abstract | 當肝臟受到長期損傷會產生纖維化的現象，而肝纖維化往往會更進一步惡化成肝硬化甚至是肝癌。慢性肝病及肝纖維化在台灣及美國都是前十大主要死因之一，但目前並沒有有效的治療方式。
在肝纖維化時，胞外基質的過度累積會影響氧氣擴散造成組織內產生缺氧的情形，而 hypoxia inducible factor 1 α (HIF1α) 是體內主要調控缺氧反應的分子。在本篇研究中，我發現在纖維化的肝臟當中， HIF1α 的 mRNA 和蛋白質表現量都會上升。這些會表現的細胞同時也會表現 epithelial adhesion molecule (EpCAM) 、 Albumin (Alb) 和 Cytokeratin 19 (CK19) ，顯示這些細胞很有可能是肝臟前驅細胞。同時我也發現 β-catenin 在纖維化的肝臟中有進核的情形，表示典型 Wnt 訊息傳遞路徑是有被活化的。這些實驗結果顯示肝臟前趨細胞在纖維化的肝臟當中是處於低氧的狀態，而且 HIF1α 可能會透過 Wnt 訊息傳遞路徑調控肝臟前趨細胞。 在細胞實驗方面，我在正常氧濃度及低氧環境下培養肝癌細胞株 Huh7 ，並分析在動物實驗中有提到的基因及蛋白質的表現量。實驗結果顯示在低氧環境下，肝臟前驅細胞的標記分子 EpCAM 和 CK19 ，以及 Wnt/β-catenin 訊息傳遞路徑的下游基因 Axin2 和 CyclinD1 的 mRNA 表現量都有上升的情形； EpCAM 和 CK19 的蛋白質表現量也有上升，也可以看到 β-catenin 有進核的情形。這些研究結果顯示在動物實驗中觀察到的肝臟前趨細胞標記以及 Wnt/β-catenin 訊息傳遞路徑活化的情形很有可能是被低氧狀態所誘導的。 | zh_TW |
| dc.description.abstract | Hepatic fibrosis is the response of liver encountering chronic injury, which would often progress to liver cirrhosis or even hepatocellular carcinoma (HCC). Chronic liver disease and liver fibrosis were in the list of top tenth cause of death in both Taiwan and the US, but no effective drug was developed for the treatment of fibrosis.
The accumulation of extracellular matrix (ECM) during liver fibrosis would lead to hypoxia due to the blockage of oxygen diffusion, and hypoxia inducible factor 1 α (HIF1α) is the main modulator of hypoxic response. Here in my research, I have detected upregulated expression of HIF1α, in mRNA as well as in protein level in fibrotic liver. The cells expressing HIF1α also expressed epithelial cell adhesion molecule (EpCAM), Albumin (Alb) and cytokeratin 19 (CK19), suggesting that these HIF1α + cells were hepatic progenitor cell (HPC)-like. I also observed translocated β-catenin in fibrotic liver, indicating the activation of canonical Wnt signal. These data proved that HPCs were localized in hypoxic area during liver fibrosis, and HIF1α may interact with Wnt/β-catenin signaling to regulate HPC. As for the in vitro experiment, I cultured HCC cell line Huh7 under normoxic and hypoxic conditions to compare the expression levels of the genes mentioned in the in vivo experiment and found out that the mRNA expression level of HPC markers, EpCAM and CK19, and Wnt/β-catenin downstream targets, Axin2 and CyclinD1, were all elevated. Increased EpCAM and CK19 protein expression, in addition to β-catenin translocation could also be observed in hypoxic cultured Huh7. These results suggested that the increased expression of HPC marker and Wnt/β-catenin signaling pathway observed in vivo could be regulated by hypoxic condition. | en |
| dc.description.provenance | Made available in DSpace on 2021-05-15T17:55:17Z (GMT). No. of bitstreams: 1 ntu-103-R01b22009-1.pdf: 1890210 bytes, checksum: 01a9bf40ba45173558099475ce710bf3 (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 口試委員審定書 i
Acknowledgement ii Abstract iii 中文摘要 v Table of Contents vi Chapter 1. Literature Review 1 1.1. Liver fibrosis and disease progression 1 1.2. Hepatic Progenitor cell (HPC) and liver disease 3 1.3. Hypoxia, hypoxia-inducible factors (HIFs) and liver disease 5 1.4. Epithelial cell adhesion molecule (EpCAM) and liver disease 7 1.5. Wnt signaling pathway and liver disease 8 Chapter 2. Aim and Experimental Flowchart 11 2.1 Motivation and Aim 11 2.2 Flowchart 11 Chapter 3. Methodology 13 3.1. Animal and CCl4 model 13 3.2. Whole liver RNA extraction 13 3.3. Hematoxylin and eosin (H&E) staining 14 3.4. Masson’s Trichrome staining 14 3.5. Liver immunofluorescence staining 14 3.6. Laser microdissection (LMD) and RNA isolation 15 3.7. Cell culture 16 3.8. Cellular RNA extraction 16 3.9. Cellular protein extraction 17 3.10. Quantitative reverse transcription PCR (qRTPCR) 17 3.11. Western blotting 18 3.12. Flow cytometry 19 3.13. Cell immunofluorescence staining 20 3.14. Image processing 21 3.15. Statistics 21 Chapter 4. Results 22 4.1 CCl4 induced fibrosis in C57BL/6 mice liver 22 4.2 Upregulated HIF1α in fibrotic liver 22 4.3 Identification of HIF1α positive cells as HPC-like cells 23 4.4 Upregulated Wnt in HPC-like cell 24 4.5 Upregulated EpCAM, Wnt and CK19 under hypoxic cultured Huh7 25 Chapter 5. Discussion and Conclusion 26 Chapter 6. Figures and Tables 29 Table 1. List of antibodies 29 Table 2. List of qRTPCR primers 31 Figure 1. H&E staining of mice liver 33 Figure 2. Masson’s trichrome staining of mice liver 34 Figure 3. Fibrotic marker mRNA expression level in whole mice liver 35 Figure 4. Immunofluorescence staining of HIF1α in mice liver 36 Figure 5. mRNA expression level of HIF1α in whole mice liver 37 Figure 6. Fibrotic markers and HIF1α mRNA expression level in LMD liver 38 Figure 7. Immunofluorescence staining of HIF1α and HPC markers 39 Figure 8. mRNA expression level of HPC markers in LMD liver 41 Figure 9. Immunofluorescence staining of Wnt/β-catenin signaling activation 42 Figure 10. mRNA expression level of Wnt downstream targets in LMD liver 44 Figure 11. Confirmation of Huh7 hypoxic culture by HIF1α and HIF2α proteins 45 Figure 12. Confirmation of Huh7 hypoxic culture by HIFs downstream targets 46 Figure 13. mRNA expression level of HPC markers in Huh7 47 Figure 14. mRNA expression level of Wnt downstream target genes in Huh7 48 Figure 15. EpCAM protein expression in Huh7 49 Figure 16. CK19 protein expression in Huh7 50 Figure 17. Immunofluorescence staining of β-catenin in Huh7 51 Figure 18. Possible mechanisms 52 Reference 53 Appendix 62 List of Abbreviations 62 | |
| dc.language.iso | en | |
| dc.subject | Wnt/β-catenin | zh_TW |
| dc.subject | EpCAM | zh_TW |
| dc.subject | 肝臟前驅細胞 | zh_TW |
| dc.subject | 肝纖維化 | zh_TW |
| dc.subject | HIF | zh_TW |
| dc.subject | 低氧 | zh_TW |
| dc.subject | Wnt/β-catenin | en |
| dc.subject | liver fibrosis | en |
| dc.subject | hypoxia | en |
| dc.subject | HPC | en |
| dc.subject | EpCAM | en |
| dc.subject | HIF | en |
| dc.title | 於小鼠肝纖維模式下探討低氧環境對肝臟細胞之影響 | zh_TW |
| dc.title | The effect of hypoxia on liver cells in mouse liver fibrosis model | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 吳金洌(Jen-Leih Wu),冀宏源(Hung-Yuan Chi),鄭永銘(??Yung-Ming Jeng),陳俊任(Chun-Jen Chen) | |
| dc.subject.keyword | 肝纖維化,低氧,肝臟前驅細胞,EpCAM,HIF,Wnt/β-catenin, | zh_TW |
| dc.subject.keyword | liver fibrosis,hypoxia,HPC,EpCAM,HIF,Wnt/β-catenin, | en |
| dc.relation.page | 62 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2014-07-15 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科技學系 | zh_TW |
| 顯示於系所單位： | 生化科技學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf | 1.85 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。